In-vitro activity of ceftriaxone combined with newer agents against MRSA.

about

In-vitro activity of ceftriaxone combined with newer agents against MRSA.

Item

http://www.wikidata.org/entity/Q48281333

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

In-vitro activity of ceftriaxone combined with newer agents against MRSA.

@en

In-vitro activity of ceftriaxone combined with newer agents against MRSA.

@nl

type

Item

label

In-vitro activity of ceftriaxone combined with newer agents against MRSA.

@en

In-vitro activity of ceftriaxone combined with newer agents against MRSA.

@nl

prefLabel

In-vitro activity of ceftriaxone combined with newer agents against MRSA.

@en

In-vitro activity of ceftriaxone combined with newer agents against MRSA.

@nl

P1476

In-vitro activity of ceftriaxone combined with newer agents against MRSA

@en

P2093

Gulseren Aktas

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia.

Study of Antibiotic Resistance Pattern in Methicillin Resistant Staphylococcus Aureus with Special Reference to Newer Antibiotic.

Effects of selection pressure and genetic association on the relationship between antibiotic resistance and virulence in Escherichia coli.

β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.

Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery.

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.

Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.

Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.

Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus

β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus.

P304

383-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1120009X.2016.1246633

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gulseren Aktas

P577

2016-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27774857

http://www.w3.org/2001/XMLSchema#string